Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013

J. Compston* (Corresponding Author), C. Bowring, A. Cooper, C. Cooper, C. Davies, R. Francis, J. A. Kanis, D. Marsh, E. V. McCloskey, D. M. Reid, P. Selby

*Corresponding author for this work

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.

Original languageEnglish
Pages (from-to)392-396
Number of pages5
JournalMaturitas
Volume75
Issue number4
Early online date27 Jun 2013
DOIs
Publication statusPublished - 1 Aug 2013

Fingerprint

Postmenopausal Osteoporosis
Osteoporosis
Guidelines
Diphosphonates
Vitamin D
Risk assessment
Glucocorticoids
Decision Support Techniques
Calcium
Therapeutics

Keywords

  • Fracture
  • FRAX
  • Guideline
  • Osteoporosis

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Obstetrics and Gynaecology

Cite this

Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK : National Osteoporosis Guideline Group (NOGG) update 2013. / Compston, J. (Corresponding Author); Bowring, C.; Cooper, A.; Cooper, C.; Davies, C.; Francis, R.; Kanis, J. A.; Marsh, D.; McCloskey, E. V.; Reid, D. M.; Selby, P.

In: Maturitas, Vol. 75, No. 4, 01.08.2013, p. 392-396.

Research output: Contribution to journalArticle

Compston, J, Bowring, C, Cooper, A, Cooper, C, Davies, C, Francis, R, Kanis, JA, Marsh, D, McCloskey, EV, Reid, DM & Selby, P 2013, 'Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013', Maturitas, vol. 75, no. 4, pp. 392-396. https://doi.org/10.1016/j.maturitas.2013.05.013
Compston, J. ; Bowring, C. ; Cooper, A. ; Cooper, C. ; Davies, C. ; Francis, R. ; Kanis, J. A. ; Marsh, D. ; McCloskey, E. V. ; Reid, D. M. ; Selby, P. / Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK : National Osteoporosis Guideline Group (NOGG) update 2013. In: Maturitas. 2013 ; Vol. 75, No. 4. pp. 392-396.
@article{f37f4d542caf48ebb49dfa30ac8a91f1,
title = "Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013",
abstract = "Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.",
keywords = "Fracture, FRAX, Guideline, Osteoporosis",
author = "J. Compston and C. Bowring and A. Cooper and C. Cooper and C. Davies and R. Francis and Kanis, {J. A.} and D. Marsh and McCloskey, {E. V.} and Reid, {D. M.} and P. Selby",
note = "The guideline development process was conducted without financial support from any commercial organisation and the members of the National Osteoporosis Guideline Group have maintained complete editorial independence.",
year = "2013",
month = "8",
day = "1",
doi = "10.1016/j.maturitas.2013.05.013",
language = "English",
volume = "75",
pages = "392--396",
journal = "Maturitas",
issn = "0378-5122",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK

T2 - National Osteoporosis Guideline Group (NOGG) update 2013

AU - Compston, J.

AU - Bowring, C.

AU - Cooper, A.

AU - Cooper, C.

AU - Davies, C.

AU - Francis, R.

AU - Kanis, J. A.

AU - Marsh, D.

AU - McCloskey, E. V.

AU - Reid, D. M.

AU - Selby, P.

N1 - The guideline development process was conducted without financial support from any commercial organisation and the members of the National Osteoporosis Guideline Group have maintained complete editorial independence.

PY - 2013/8/1

Y1 - 2013/8/1

N2 - Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.

AB - Since the launch in 2008 by the National Osteoporosis Guideline Group (NOGG), of guidance for the diagnosis and management of osteoporosis in postmenopausal women and older men in the UK there have been significant advances in risk assessment and treatment. These have been incorporated into an updated version of the guideline, with an additional focus on the management of glucocorticoid-induced osteoporosis, the role of calcium and vitamin D therapy and the benefits and risks of long-term bisphosphonate therapy. The updated guideline is summarised below. The recommendations in the guideline are intended to aid management decisions but do not replace the need for clinical judgement in the care of individuals in clinical practice.

KW - Fracture

KW - FRAX

KW - Guideline

KW - Osteoporosis

UR - http://www.scopus.com/inward/record.url?scp=84880265582&partnerID=8YFLogxK

U2 - 10.1016/j.maturitas.2013.05.013

DO - 10.1016/j.maturitas.2013.05.013

M3 - Article

C2 - 23810490

AN - SCOPUS:84880265582

VL - 75

SP - 392

EP - 396

JO - Maturitas

JF - Maturitas

SN - 0378-5122

IS - 4

ER -